U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX2187136: GSM2326867: sKH1_siREVI1-D4-Replicate1; Homo sapiens; RNA-Seq
1 ILLUMINA (Illumina HiSeq 2500) run: 40.1M spots, 11G bases, 4.6Gb downloads

Submitted by: NCBI (GEO)
Study: RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq)
show Abstracthide Abstract
RUNX1 is a frequent target of translocations in acute myeloid leukemia whereby its DNA binding domain fuses to different epigenetic regulators. To assess how different RUNX1 fusion proteins interact with the epigenome we compared the global binding patterns and the chromatin landscape of t(8;21) and t(3;21) AML which express RUNX1-ETO and RUNX1-EVI-1, respectively. We found that differential prognosis for these types of AML is reflected in fundamental differences in gene expression, chromatin landscape, binding patterns of the fusion proteins and other transcription factors as identified by genome-wide digital footprinting in patients. As previously shown for RUNX1-ETO, knockdown of RUNX1-EVI-1 expression initiates differentiation of t(3;21) cells which is associated with up-regulation of genes vital for myeloid differentiation, including C/EBPa. Furthermore, by expressing either dominant-negative C/EBP or an inducible C/EBPa construct in t(3;21) cells we show that C/EBPa is necessary and sufficient for the differentiation response of these cells to RUNX1-EVI-1 knockdown. Overall design: RNA-seq expreiments have been used to study the chromatin landscape of t(8;21) and t(3;21) AML
Sample: sKH1_siREVI1-D4-Replicate1
SAMN05806637 • SRS1709974 • All experiments • All runs
Organism: Homo sapiens
Library:
Instrument: Illumina HiSeq 2500
Strategy: RNA-Seq
Source: TRANSCRIPTOMIC
Selection: cDNA
Layout: PAIRED
Construction protocol: RNA was isolated from SKH-1 cells by TrizolTM (Life Technologies, US) as by manufacturer’s instructions. At the last step of the protocol RNA was resuspended in 17µl of RNAse free water to which was added 2µl of 10x buffer supplied with the Ambion Turbo DNaseI (Thermos Scientific, USA), of which 1 µl was added. All of which was incubated at 37ºC for 30 minutes. The RNA solution was then purified using a Nucleospin RNA clean up column (Machery Nagel, France), according to their instructions. The quality of RNA from all methods was assessed using a spectrophotometer, by the ratio of the absorbance at 260nM and 280nM wavelengths. RNA has a greater absorbance in the 260nM wavelength, Eukaryotic Total RNA PICO Bioanalyser chip (Agilent technologies, USA) allows visualisation of the size of the RNA molecules and thus, demonstrates whether the sample is degraded or not RNA-seq libraries were prepared with a Total RNA Ribo-zero library preparation kit (with ribosomal RNA depletion) (Illumina, USA) according to manufacturer’s instructions with the following alterations: 15 cycles of PCR was undertaken to amplify the library and adaptors for multiplexing were used at a 1:4 dilution. Library quality was checked by running the samples on a Bioanalyser and libraries were quantified using a Kapa library quantification kit (Kapa Biosystems, USA) and run in a pool of eight indexed libraries in two lane of a HiSeq 2500 (Illumina, USA) using rapid run chemistry with 100bp paired end reads.
Experiment attributes:
GEO Accession: GSM2326867
Links:
Runs: 1 run, 40.1M spots, 11G bases, 4.6Gb
Run# of Spots# of BasesSizePublished
SRR429164240,083,08511G4.6Gb2017-06-27

ID:
3182352

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...